Friday, January 08, 2021 4:30:05 PM
There are two questions: are the stories all lies or are the products real?
From what I can tell, the products are real even if the sleight of hand, continual filings moving things around drives me crazy.
What's the option? Sell for a loss? Or hold and see if these products can find their right niche? Seems to me medical waste, AI, DNA and cancer research with a warehouse of cancer samples is a bet worth staying with.
These docs are not nice to us investors. I imagine they're mad, too. They wanted to hit it big a decade ago and then the world kept falling apart. One of these days we all hope they find the right hit which catapults them into the big leagues. If that happens, this board quickly changes.
Recent POAI News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 10:00:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 10:00:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/07/2023 01:54:30 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/05/2023 09:15:47 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 10:16:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 09:06:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 09:06:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 09:05:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 09:03:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 09:03:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/27/2023 10:25:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/17/2023 08:02:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 09:16:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 09:11:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 01:05:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 01:04:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 01:03:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 01:02:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 01:01:26 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM